Company Quick10K Filing
⚲
Everflow Eastern Partners
Filings
10-Q 2020-09-30 Filed 2020-11-12
10-Q 2020-06-30 Filed 2020-08-13
10-Q 2020-03-31 Filed 2020-05-14
10-K 2019-12-31 Filed 2020-03-26
10-Q 2019-09-30 Filed 2019-11-13
10-Q 2019-06-30 Filed 2019-08-13
10-Q 2019-03-31 Filed 2019-05-13
10-K 2018-12-31 Filed 2019-03-27
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-10
10-Q 2018-03-31 Filed 2018-05-11
10-K 2017-12-31 Filed 2018-03-27
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-28
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-11
10-K 2015-12-31 Filed 2016-03-25
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-12
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-03-27
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-13
10-Q 2014-03-31 Filed 2014-05-13
10-K 2013-12-31 Filed 2014-03-26
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-13
10-K 2012-12-31 Filed 2013-03-28
10-Q 2012-09-30 Filed 2012-11-13
10-Q 2012-06-30 Filed 2012-08-13
10-Q 2012-03-31 Filed 2012-05-11
10-K 2011-12-31 Filed 2012-03-27
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-12
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-29
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-31
Reports

Everflow Eastern Partners Financials

EEPL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin
Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)
Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash21,340,48521,29921,25760,95028,77232,21725,39724,11223,36323,24624,46224,33125,61125,09725,35423,80623,84923,06022,73421,64111,58611,43011,22511,68613,27311,51211,8848,72310,27011,95312,56713,56413,52511,649
Accounts Receivable9069635735415225681,0151,3431,4159771,1901,3131,3891,0901,6621,9751,2841,046
Inventory
PP&E176,469,556177,090177,126177,115177,098176,824176,761176,955177,057177,793177,571177,607177,564176,968179,970180,070180,070179,818184,040184,037184,037184,238184,246184,022183,933183,933181,952180,993178,260177,742177,920177,869177,796177,680
Assets67,522,13065,95566,151103,55969,31271,74463,31960,33058,55457,66359,19758,18358,58757,05458,95956,11054,61952,64838,60336,35235,25834,33432,90733,43634,94235,54635,99836,30137,82939,16340,64841,94341,33241,678
Accounts Payable1,915,2252,1831,8866,4702,4862,8282,2252,4412,0622,1821,6851,8031,9551,8351,8201,8111,8931,8201,8401,8001,8001,7531,7031,6951,8781,9381,9581,8921,8951,8571,8702,0852,0862,152
Long-Term Debt
Liabilities9,336,1579,7909,99220,04116,07816,87314,01510,73710,52911,06011,23910,70210,98411,04715,24514,52114,82515,01620,44319,97220,14920,39820,70920,47920,83921,31221,72521,27121,15721,44921,93821,85922,21222,380
Stockholders' Equity58,185,97356,16556,15983,51853,23554,87249,30449,59348,02546,60347,95847,48147,60346,00743,71441,58939,79437,63218,16016,38015,10913,93712,19812,95714,10314,23414,27315,03016,67217,71518,71020,08419,12019,298
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue5,950,3745,6335,0014,8553,4103,9614,0174,3094,3394,3774,4133,7724,1313,4522,4842,1971,6881,5868687618688921,3612,3542,2671,3871,6532,2062,4412,7652,8931,9351,429
Cost of Revenue8770
Gross Profit1,8481,359
R&D
SG&A557,2775326487767655611,0966885265559786677065211,125671588501949608542505661580491535658587523518603493546
Tax25,00010213,357411953,13753436425-701100012-1-1-1060-0-0-1800054001100
Net Income2,703,9412,2422,83630,20028,2915,1582,3833,1281,2951,4152,7739421,5801,238-876-708-1,025-749-19,047-1,780-1,270-1,173-1,7397593,079131397572,2721,0431,374806178
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-8,338,5483,7908,136-1,1382,762-1,5231,6812,2523,2542,8801,3382,6302,5401,654-2968347990-1,127704511,4184403231,6261,7931,1381,855879
Cash Investing1,004,933-98934,398-5024,2822,654-127-184-488-245-5029-14219-1028269835-7410168-68-3,484-83-102-141-254-2,625
Cash Financing5,655,874-2,842-2,842-30,538-3,599-7,950-2,839-2,816-2,884-1,419-1,419-1,380-2,912-1,417-1,417-647-1,536-42400-8-130